Biotech Co. Xencor Sets Stage For $150M Follow-On Offering
California-based biopharmaceutical company Xencor Inc. on Wednesday laid out plans to raise $150 million in a follow-on offering to fund research and development of its potential treatments for autoimmune diseases....To view the full article, register now.
Already a subscriber? Click here to view full article